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Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that selectively affects upper 
and lower motoneurons. Dismantlement of the neuromuscular junction (NMJ) is an early pathological 
hallmark of the disease whose cellular origin remains still debated. We developed an in vitro NMJ model 
to investigate the differential contribution of motoneurons and muscle cells expressing ALS-causing 
mutation in the superoxide dismutase 1 (SOD1) to neuromuscular dysfunction. The primary co-culture 
system allows the formation of functional NMJs and fosters the expression of the ALS-sensitive fast 
fatigable type II-b myosin heavy chain isoform. Expression of SOD1G93A in myotubes does not prevent 
the formation of a functional NMJ but leads to decreased contraction frequency and lowers the slow 
type I myosin heavy chain isoform transcript level. Expression of SOD1G93A in both motoneurons and 
myotubes or in motoneurons alone however alters the formation of a functional NMJ. Our results strongly 
suggest that diseased motoneurons are a major factor involved in the process of NMJ dismantlement in 
an experimental model of ALS. 
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 Myotubes expressing the ALS-causing SOD1 mutant show reduced contraction frequency  
 The presence of mutated SOD1 in myotube leads to reduced levels of the slow myosin heavy 
chain isoform 







































































ALS is a fatal neurodegenerative disease characterized by early denervation of the NMJ and death of 
motoneurons leading to progressive muscular paralysis. It is now demonstrated that motoneuron 
degeneration is not an exclusive cell-autonomous process but involves different cell types (Taylor et al., 
2016). Skeletal muscle is the main target of motoneurons and a major player in motoneuron survival 
and synaptogenesis during development (Oppenheim, 1989). Mice overexpressing ALS-associated 
mutated human SOD1 specifically in skeletal muscles develop progressive muscle atrophy with 
mitochondrial dysfunction (Dobrowolny et al., 2008, Wong and Martin, 2010). Such alterations that 
impact skeletal muscle metabolism can induce NMJ instability, a contributing factor to muscle weakness 
and motoneuron degeneration (Dupuis et al., 2009, Loeffler et al., 2016). It was thus proposed that 
skeletal muscle is a causal factor of ALS pathology. However, it was subsequently shown that improving 
muscle metabolism is not sufficient to extent survival of ALS mice suggesting that skeletal muscle does 
not actually influence motoneuron survival in this neurodegenerative disease (Da Cruz et al., 2012). In 
addition, the RNA interference-mediated reduction of SOD1 mutant in skeletal muscle does not alter the 
course of the disease in mice (Towne et al., 2008). More recently, it was proposed that muscle-secreted 
factors might contribute to NMJ destabilization and axon degeneration (Maimon et al., 2018). 
In addition to the role of muscle metabolism in ALS progression, the contribution of satellite cells to 
muscle dysfunction has also drawn attention. Indeed, muscle undergoes continuous fiber renewal 
throughout our life course and following injury. This process is ensured by resident satellite cells. These 
myogenic precursors are responsible for muscle formation, are activated during regeneration following 
muscle injury and play a key role in the maintenance of muscle mass (Charge and Rudnicki, 2004). 
Degenerative conditions, including aging and defects in satellite cell regulation, can impair muscle 
regeneration (Dumont et al., 2015). Abnormalities of satellite cells and repair capacity have also been 
observed in ALS patients (Pradat et al., 2011) and in a mouse model of the disease (Manzano et al., 
2013), suggesting a loss in their muscle renewal ability that could contribute to muscle atrophy in ALS. 
Little is known regarding the independent contribution of muscle and motoneuron for NMJ formation and 
dismantling in ALS. To address their specific roles under pathological conditions, we set-up an in vitro 
model which allows assessing the potential of satellite cells to differentiate into myotubes and make a 





B6.Cg-Tg(SOD1*G93A)1Gur/J (Jackson Laboratory, USA) and Hb9::GFP mice (T.M. Jessell’s 
laboratory, Columbia University, NY, USA) were maintained on a C57BL/6J background under specific-
pathogen-free conditions . All animal experiments were approved by the national ethics committee on 
animal experimentation, and were done in compliance with the European community and national 
directives for the care and use of laboratory animals. 11 mice were used for myoblasts banks and 9 






































































Motoneuron cultures were isolated from the spinal cord of Hb9::GFP and SOD1G93A mice at embryonic 
day (E) 12.5 (Raoul et al., 2002). Ventral part of the spinal cord from GFP-positive and GFP-negative 
littermate embryos were collected, pooled separately and dissociated mechanically following trypsin 
treatment. Cell homogenate obtained from Hb9::GFP spinal cords were then submitted to iodixanol 
density gradient centrifugation to enrich in motoneurons. In order to facilitate the development of 
spontaneous activity in culture while being able to easily visualize the motoneurons for 
electrophysiological recording, Hb9::GFP motoneurons are seeded with the total GFP-negative fraction 
(containing also glial cells and interneurons). 
 
Myoblast isolation and differentiation 
For primary culture of satellite cells, we used the offspring of female C57BL/6J and male SOD1G93A 
mice. Five wild type (WT) and six SOD1G93A primary cultures were generated for this study. Satellite 
cells were obtained from hind limb muscles of 3-4 weeks old mice (pre-symptomatic for SOD1G93A). After 
mincing muscles, an enzymatic digestion was performed in Ham’s F10 medium (ThermoFisher 
Scientific) supplemented with 2.5 mM CaCl2, 0.5 mg/ml dispase II (Sigma-Aldrich) and 10 mg/ml 
collagenase B (Sigma-Aldrich). Following 15 min incubation twice at 37°C, a mechanical dissociation 
was performed. Muscle digest was passed through a 70 µm mesh filter, transferred to a 15 ml tube and 
spinned 5 min at 1000 rpm. The pellet was diluted in culture medium (Ham’s F10, 20% fetal bovine 
serum, 2% penicillin/streptomycin, 2.5 ng/ml recombinant human fibroblast growth factor-basic (bFGF, 
ThermoFisher Scientific) and placed in a 60 mm diameter uncoated plastic plate for 1 hr to favor 
fibroblasts adherence. Afterwards, the medium solution was then removed and transferred into a plate 
coated with collagen at 37°C, 7 % CO2. Satellite cells were allowed to multiply until they reach 70-80 % 
confluence and then split with 0.25 % trypsin to enhance the colony. Experiments were performed from 
third to fifth passage. For myoblasts differentiation and fusion, the serum was decreased to 2%. 
 
Co-cultures 
For motoneuron-myotube co-cultures, myoblasts were seeded on glass coverslips (1.5 cm2) coated with 
poly-ornithine-laminin at a density of 10,000 /cm2. After 2-3 days in multiplication medium, the medium 
was removed and motoneurons were added (1,700 / cm2) in Neurobasal (Fisher Scientific) medium 
containing neurotrophic factors (1 ng/ml BDNF, 100 pg/ml GDNF, and 10 ng/ml CNTF), completed with 
2% horse serum, 2% B27 supplement (ThermoFisher Scientific), 50 µM L-glutamine, 25 µM L-
glutamate, and 25 µM -mercaptoethanol. The low serum concentration of motoneuron culture medium 
allows the differentiation of myoblasts into myotubes. The co-culture was maintained at 37°C, in 







































































Spontaneous electrical activity of motoneurons and myotubes was recorded with the loose-patch 
technique at room temperature using an Axopatch 200B amplifier (Molecular Devices). The bathing 
solution contained 145 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1.5 mM MgCl2, 10 mM glucose and 10 mM 
HEPES, adjusted to pH 7.35. For excitatory post-synaptic potentials visualization, the motoneuron 
spontaneous electrical activity was recorded under whole-cell patch clamp with the patch pipette 
containing 8 mM KCl, 135 mM K-methane-sulfonate, 2 mM Mg-ATP, 0.5 mM Na-GTP, 0.1 mM EGTA 
and 10 mM HEPES, adjusted to pH 7.35. For loose-patch technique, the electrode was filled with the 
extracellular solution and the contact with cell membrane was in the range 30-80 MΩ. 6-cyano-7-




For live imaging, myotube contractions were recorded with the high-speed Orca-flash 4.0LT CCD 
camera (Hamamatsu Photonics) coupled with HCImage DIA software and connected to the inverted 
microscope used for electrophysiology. Acquisition period was 30 sec (28 fps). Phase contrast images 
of live cultures were acquired with the CCD camera. 
 
Immunocytochemistry 
Primary cultures at 7-8 DIV were fixed for 15 min in 4% paraformaldehyde in PBS, and incubated for 20 
min in 15% donkey serum in PBS. They were then incubated 2 h at room temperature with the primary 
antibodies. After a wash in PBS, cultures were incubated for 1h at room temperature with secondary 
antibodies. After three washes in PBS, 10 min each, they were mounted in Mowiol. alpha-bungarotoxin 
Alexa Fluor 555 conjugate (1:1000, ThermoFisher Scientific) was added at the last wash before 
mounting. Primary antibodies were chicken anti-GFP to enhance staining of Hb9::GFP neurons (1:3000, 
Abcam); mouse anti-myosin heavy chain, MHC (clone A4.1025, 1:100, Developmental Studies 
Hybridoma Bank), mouse anti-rapsyn (1:100, Abcam), mouse anti-S100 (1:100, Novus Biologicals), 
goat anti-vesicular acetylcholine transporter (VAChT) (1:400, Merck Millipore), guinea pig anti-vesicular 
glutamate transporter 2 (VGluT2) (1:1000, synaptic systems). Fluorochrome-conjugated secondary 
antibodies (ThermoFisher Scientific) were used at 1:1000. Images were collected using Zeiss 40X EC 
Plan Neofluar 1.3NA oil objective.  
 
RNA extraction and RT-qPCR 
Myoblasts were seeded at the density of 10,000 /cm2 in 60 mm diameter dishes. Total mRNA was 
extracted 2-3 days after seeding in multiplication medium and at 7 DIV after changing to a differentiation 
medium with the RNeasy Mini Kit (Qiagen). Following 2 min incubation in lysis buffer, 70% ethanol was 
added to equal volume and total mRNA was obtained using RNeasy minispin columns. The eluted 




































































genomic DNA wipe out, reverse transcription (RT) was performed with 1 µg of mRNA with the Quantitect 
RT kit (Qiagen). The collected cDNA was diluted to 100 ng with water and stored at -20°C until use. 
Primers were designed with Primers 3.0 software. Quantitative PCR was performed on 5 or 10 ng cDNA 
with SYBR Green (Qiagen) for detection and the LightCycler system (Roche Diagnostics). After initial 
activation for 15 min at 95°C, 45 cycles of 94°C for 15 s, 60°C for 20 s and 72°C for 35 s were carried 
out. After PCR amplification, a melting curve analysis was carried out to check PCR specificity. 
Polymerase (RNA) II polypeptide J (Polr2J) levels were used to normalize the amounts of cDNA. ΔCt 
was calculated as the differences between the Ct values, determined with the equation 2–ΔCt. Primers 
sequences are given in Table 1. 
 
Statistics 
Data are presented as means ± standard error of the mean (SEM) or as median for non-parametric test. 
Statistical significance was accepted at the level of p < 0.05. Unpaired or paired two-tailed t test, X2 




Pharmacological profile of spontaneous activity of motoneurons and myotubes in primary 
culture  
Before assessing the formation of a functional NMJ in motoneuron-myotubes co-cultures, we aimed to 
set the phenotypic and pharmacological characteristics of each culture. We previously shown that, from 
7 days in vitro (DIV), cultured primary motoneurons display adult-like intrinsic electrical activity 
(Bowerman et al., 2017). In primary culture, We isolated motoneurons from mice expressing GFP under 
the control of the motoneuron-selective Hb9 promoter (Hb9::GFP) to facilitate motoneuron identification. 
Hb9::GFP motoneurons express the vesicular acetylcholine transporter (VAChT) a cholinergic marker 
and the vesicular glutamate transporter 2 (VGluT2), a glutamatergic marker (Fig. 1A, left panel). This 
observation is in agreement with studies showing that motoneurons have not a single neurotransmitter 
phenotype and can release both Acetylcholine and Glutamate (Nishimaru et al., 2005, Lamotte 
d'Incamps et al., 2017). The Hb9::GFP negative neurons express only VGluT2, identifying putative 
glutamatergic interneurons (Fig.1A, right panel). The primary culture also contains glial cells expressing 
the S100 marker, which can be observed in close vicinity of the motoneurons (Fig. 1B). Using loose 
patch-clamp technique, a spontaneous electrical activity was recorded in GFP-positive motoneurons 
(Fig. 1B, C). The probability to record a spontaneous activity at 7-8 DIV was strongly increased using a 
mixed ventral horn culture composed of motoneurons, interneurons and glial cells. Thereafter, we used 
mixed ventral horn cultures for all experiments. The basal spontaneous frequency was 0.53 ± 0.12 Hz, 
n = 22. This spontaneous activity was inhibited following addition of 50 µM 6-cyano-7-nitroquinoxaline-
2,3-dione (CNQX) to block AMPA/kainate receptors, but was not modified by 50 µM d-tubocurarine (d-
TC) that blocks nicotinic receptors. These observations support that motoneuron spontaneous activity 




































































After 7-8 DIV in differentiation medium and despite the absence of motoneurons, a small proportion of 
myotubes displays spontaneous contractions as assessed during 30 min observation per well (3.7 ± 1.3 
contracting myotubes per well, n = 3 cultures). These spontaneous contractions have already been 
attributed to maturation of electrical activity of mouse myotubes (Lorenzon et al., 2002, Das et al., 2009). 
Using videomicroscopy for contraction recordings (Fig. 1F and Movie 1), we show that the contraction 
frequency was of 1.7 ± 0.2 Hz, n =10. Myotubes spontaneous contractions were not inhibited by CNQX 
(Fig. 1 G, H), while application of d-TC induced a fibrillation-like pattern characterized by an increase in 
contraction frequency associated with a decrease in amplitude, leading in most cases to a contracture 
(Fig. 1 G, H and Movie 1). This observation is in agreement with previous studies that reported that d-
TC can have fibrillary effect on denervated muscle and depolarizes embryonic muscle fibers (Ziskind 
and Dennis, 1978, Smith et al., 2013). In all cases, application of 1 µM TTX totally inhibited spontaneous 
contractions. (Fig. 1 G, H and Movie 1). Coupling videomicroscopy recordings of myotubes contractions 
with extracellular recordings of their electrical activity confirmed that each contraction is associated with 
an electrical spike (Fig. 1 I). 
From these data, we selected CNQX, as a specific inhibitor of synaptic-driven neuronal activity, to 
assess the formation of neuron-driven contractions. 
 
Co-cultured myotubes-motoneurons increase neuronal network activity, but not contraction 
frequency of myotubes 
We next analyzed the effects of the presence of motoneurons on the spontaneous activity of myotubes. 
Addition of wild-type (WT) motoneurons to myotube culture induces a two-fold increase in the number 
of myotubes having contractions (Fig. 2A). To assess the formation of NMJ, a morphological analysis 
was performed using fluorochrome-conjugated alpha-bungarotoxine (BTX) to label nicotinic 
acetylcholine receptors. The staining was evident as clusters on most myotubes, while apposition with 
process endings of motoneurons, labelled with GFP, was observed only in few myotubes (Fig. 2B). NMJ 
expressed the post-synaptic marker of maturation Rapsyn in close proximity with BTX and the neuronal 
pre-synaptic VAChT shows close apposition with the nicotinic receptors (Fig. 2 C) with a morphology 
consistently observed in vitro (Zahavi et al., 2015, Vilmont et al., 2016). Spontaneous electrical activity 
of myotube (contracting myotube) and motoneurons was recorded using loose-patch clamp (Fig. 2 C, 
D). The electrical activity frequency of WT contracting myotubes in co-culture was 1.7 ± 0.2 Hz, n = 27, 
a value similar to the spontaneous contraction frequency (Fig. 2 E), while in the presence of WT 
myotubes, there was a significant three-fold increase in motoneuron spontaneous firing frequency (Fig. 
2F). 
 
SOD1G93A myotubes display reduced contraction frequency 
To assess the effect of SOD1G93A mutant on myotube contraction frequency, myotubes obtained from 
muscle satellite cells of SOD1G93A mice were analyzed in the presence of WT motoneurons. Mutant 
myotubes display a significantly two-fold lower contraction-associated spike frequency than WT (Fig. 




































































frequency, we combined videomicroscopy with loose patch recordings and found that, similarly to what 
observed with WT myotubes, each contraction of SOD1G93A myotube was associated with an electrical 
spike (Fig. 3B, C). Analysis of the time for the contraction-relaxation cycle revealed no significant 
differences between WT and mutant myotubes (550 ± 57 ms, n = 13 and 621 ± 66 ms, n = 14 for WT 
and mutant myotubes, respectively (two-tailed t test t(25) = 0.807, p ≥ 0.05; F(13,12) = 1.458 p ≥ 0.05). 
Furthermore, the presence of SOD1G93A myotubes, does not modify the spontaneous firing frequency 
of WT motoneurons as compared with WT myotubes (1.3 ± 0.3 Hz, n = 20, from 3 co-cultures) (Fig. 3D). 
Thus, SOD1G93A myotubes display lower contraction frequency than WT that appears to not be 
associated with changes in motoneuron electrical network or in contraction-relaxation duration. 
 
SOD1G93A reduces the expression of the slow myosin heavy chain isoform in myotubes 
Contraction is dependent on myotube maturation state and expression of myosin heavy chain (MHC) 
isoforms (Schiaffino and Reggiani, 2011). Therefore, we investigated the process of WT and SOD1G93A 
myoblasts differentiation in vitro using the expression of the transcription factor, paired box 7 (Pax7), a 
marker of myoblasts proliferation (Dumont et al., 2015) and creatine kinase muscle isoform (Ckm) a 
myogenic differentiation marker. Quantitative PCR on myoblasts culture (Fig. 4A) and 7 days after the 
induction of differentiation (Fig. 4B) shows similar changes in Pax7 and Ckm levels of expression 
between WT and SOD1G93A (Fig. 4C, D). These results suggest that the maturation process in vitro is 
not modified by the mutation. 
We next analyzed the expression of different MHC isoform transcripts during differentiation, as they are 
major markers of skeletal fibers types (Schiaffino and Reggiani, 2011). During the process of 
differentiation, the expression of the skeletal muscle embryonic myosin heavy chain isoform, Mhy3, 
remained unchanged and there was a significant increase in the Myh8 neonatal isoform (Fig. 4E, F). 
Analysis of the three adult isoforms, Myh2, 4 and 7, displayed no significant changes in the fast fatigue 
resistant type II-a isoform, Myh2, expression during differentiation (Fig. 4G), while there was a significant 
increase in the transcript expression of the fast fatigable type II-b isoform, Myh4, during differentiation 
of both WT and SOD1G93A myotubes (Fig. 4H). In addition, the slow type I isoform, Myh7, expression 
levels were significantly decreased during differentiation of SOD1G93A-expressing myotubes (Fig. 4I). 
Additional analysis of Myh7 expression in WT and SOD1G93A myoblasts shows no significant differences 
in median values, supporting further a decrease during the differentiation process of SOD1G93A 
myoblasts (Mann-Whitney test, U(6,6) = 16.5, p ≥ 0.05). Altogether, these results demonstrate that 
myoblast differentiation in vitro mainly drives the expression of the neonatal and fast fatigable II-b fiber 
markers both in WT and SOD1 mutant myotubes. Interestingly, SOD1G93A expression in myotubes 
decreases the level of the slow type fiber marker Myh7. 
 
SOD1G93A expression in motoneurons impairs formation of functional NMJ 
To evidence whether functional NMJs were formed, we analyzed the effects of CNQX on the contracting 
myotubes as this pharmacological agent selectively inhibits the ionotropic glutamatergic drive of 




































































% of WT myotubes (8 out of 9, from 2 different co-cultures). The effects of d-TC on co-cultured myotubes 
were similar to those observed in aneurally cultured myotubes, i.e. it induces a strong decrease in 
amplitude of contraction associated with a fibrillation-like pattern in the frequency from 1.4 ± 0.1 Hz to 
4.0 ± 1.0 Hz (n = 3 myotubes, 1 culture, not shown). These results suggest that myotube contraction in 
co-culture is due to acetylcholine release driven by glutamate depolarization of motoneurons (Fig. 5A, 
E). In SOD1G93A myotubes, CNQX inhibited contractions in 78 % of myotubes (13 out of 18, from 3 
different co-cultures), this inhibition being not significantly different from that observed with WT 
myotubes (Fig. 5B, E). To reproduce the in vivo configuration and in order to answer the question of 
whether SOD1 mutation in spinal cord could influence neurotransmission at the NMJ, SOD1G93A-
expressing myotubes were co-cultured with neuronal culture from the ventral horn of SOD1G93A spinal 
cord. Under this condition, CNQX inhibited contractions in only 22 % of mutated myotubes (2 out of 11, 
from 2 different co-cultures)(Fig. 5C, E). Lastly, to assess whether neuronal expression of SOD1G93A is 
a condition sufficient for reducing the functional formation of a NMJ, mutated neuronal culture was co-
cultured with WT myotubes. Under this condition, CNQX inhibited 11 % of WT myotube contractions (1 
out of 9, from 3 different co-cultures) (Fig. 5D, E). Altogether, these results support that spinal SOD1G93A 
expression is a major contributor to the loss of neurotransmission at the NMJ. 
 
DISCUSSION 
Here, we describe a co-culture model that recapitulates both developmental and injury-associated 
regenerative synaptogenesis and allows discriminating the effects of ALS-causing protein on muscular 
function. We show that enrichment with interneurons and glial cells increases the frequency of excitatory 
synaptic activity, which could be attributed in part to glial cells known to increase the number of 
glutamatergic ionotropic receptors (Ullian et al., 2004). In addition to the well-known trophic effects of 
muscle-derived factors on motoneuron survival, (Oppenheim, 1989, Arce et al., 1998), our results 
indicate that even in the presence of neurotrophic factors, glia and interneurons, the addition of 
myotubes increases the spontaneous firing frequency of motoneurons suggesting that myotubes do also 
add to the maturation of the glutamate-driven network. Expression of SOD1G93A in myotubes does not 
modify the spontaneous firing of motoneurons, suggesting that the ALS-linked mutant protein does not 
alter the influence of myotube on motoneuron network maturation. However, mutant myotubes present 
lower contraction frequency than WT supporting intrinsic modifications induced by SOD1G93A expression 
(Dobrowolny et al., 2008). 
To decipher molecular basis for the decreased contraction frequency in mutant myotubes, we analyzed 
the intrinsic potential of MHC isoforms to differentiation towards adult isoforms. Our data show that, in 
vitro, myotubes from both genotypes mainly increase fast fatigable type II-b Myh4 expression of MHC 
during maturation, which suggests that our culture system fosters the glycolytic pathway over the 
oxidative. In a previous study, we showed that, independently of intrinsic maturation, the level of the two 
adult fast isoforms Myh2 and Myh4 expression is lower in mutant myotubes (Varga et al., 2018). So, 
independently of gene expression levels, the major up-regulation of the fast fatigable type II-b Myh4 




































































intrinsic metabolic alterations of the fast isoforms are reported in ALS mice including altered glucose 
metabolism and a metabolic switch towards lipid use (Smittkamp et al., 2014, Palamiuc et al., 2015, 
Dobrowolny et al., 2018). The fast fiber type shows high shortening velocity and overexpressed 
SOD1G93A influences their contractile properties towards slower relaxation (Derave et al., 2003), which 
could contribute to the lower contraction frequency of SOD1G93A myotubes. However, the lack of 
differences in contraction duration between WT and mutant myotubes does not support this hypothesis. 
In addition to the fast isoforms, we show that the slow Myh7 isoform expression is decreased in mutant 
myotubes during the process of maturation and has a trend towards a decrease in mutant myotubes 
compared with WT (Varga et al., 2018). Therefore, this isoform appears to be the most affected by the 
mutation with an overall decrease in its expression level. From a functional point of view, this isoform is 
regulated by calcineurin, a molecular decoder of sustained intracellular Ca2+ signals that occurs during 
contractions (Olson and Williams, 2000). Therefore, Myh7 could be a marker of myotubes and myoblasts 
having spontaneous contractions. Its reduced expression in SOD1G93A myotubes agrees with the 
decrease in calcineurin activity in ALS (Ferri et al., 2004) and suggests that SOD1G93A myotubes are 
less excitable. Muscle excitability threshold is dependent on numerous factors including the fiber type, 
the slow type having the lowest threshold (Pierno et al., 2002), the muscle ionic channels whose 
expression is modified in ALS mice (Camerino et al., 2019). Synaptic strength of motor units of fast and 
slow muscle fibers is also differentially affected by SOD1 mutation early in the disease (Tremblay et al., 
2017), which could account for a reduced contraction frequency in mutant myotubes provided that the 
fast type Myh4 expression dominates myotube contractions. Biophysical factors such the rheological 
properties that comprise cell elasticity could also influence the contractile dynamics. In support to this, 
using atomic force microscopy, we reported that mutant myotubes display a hardest structure than WT 
which could contribute to reduced contraction dynamics (Varga et al., 2018). 
In agreement with the formation of functional NMJs, we show that addition of motoneurons increases 
the number of contracting myotubes and 89% of them were sensitive to CNQX inhibition. When 
SOD1G93A is overexpressed in myotubes, there was a trend towards a decrease in the occurrence of 
CNQX-sensitive contraction to 78% of myotubes which was however not significant and supports that 
the process of neurotransmission is not merely affected by muscle SOD1G93A expression. In contrast, 
expression of SOD1 mutant in motoneurons greatly decreases the probability to make a functional 
synapse with SOD1G93A-expressing myotubes to 22% of CNQX-sensitive contractions. The formation 
and stability of a NMJ depend on factors secreted by motoneurons (Sanes and Lichtman, 2001). 
Recently, expression of Wnt3 protein by motoneurons was shown to promote the aggregation of 
acetylcholine receptors on muscles (Henriquez et al., 2008, Shen et al., 2018). Interestingly, decreased 
expression of Wnt3 has been reported in ALS limb muscles (McLoon et al., 2014). The overall process 
of motoneuronal secretion, including neurotransmitter release, alongside a slowing of vesicular transport 
could also contribute to the delay in myotube innervation (Williamson and Cleveland, 1999). Moreover, 
impaired re-innervation following nerve crush is shown in SOD1G93A mice which could also explain the 
delay or loss of innervation we observe in our mixed developmental and injury-associated regenerative 
synaptogenesis (Pun et al., 2006, Schram et al., 2019). Indeed, these studies show that mutant 




































































deficiency, mutant astrocytes display toxic effects on motoneurons which probably contributes to the 
reduced functional NMJ induced by neuronal SOD1G93A culture (Aebischer et al., 2011, Yamanaka and 
Komine, 2018).  
In conclusion, this study provides relevant information on the development of neuromuscular defects 
during ALS progression. Our results strongly support that diseased motoneurons are a major factor 




We are grateful to the Montpellier RIO Imaging and the INM animal facility for their services. This work 
was supported by grants from the Institut National de la Santé et de la Recherche Médicale (Inserm), 
the association pour la recherche sur la SLA (ARSLA, grant number R14071FF), ANR Mimetic (grant 
number 15-CE18-0017), association française contre les myopathies (AFM, grant number 19496) and 
LabEx NUMEV (ANR-10-LABX-20). R.Y. is supported by Lebanese University (PhD fellowships). M.B. 
was an EMBO Long-Term Fellow whilst at the INM. 
 
 
CONFLICT OF INTEREST STATEMENT 




F.S and C.H designed the research 
S.B, A.S-V, V.M, R.Y, O.L, C.S, R.Y, M.B, C.H, F.S performed the research 
C.G, M.B, C.R, C.H, F.S analyzed the data 






































































Aebischer, J., Cassina, P., Otsmane, B., Moumen, A., Seilhean, D., Meininger, V., Barbeito, L., 
Pettmann, B. and Raoul, C., 2011. IFNgamma triggers a LIGHT-dependent selective death of 
motoneurons contributing to the non-cell-autonomous effects of mutant SOD1. Cell Death Differ. 18, 
754-768. 
Arce, V., Pollock, R. A., Philippe, J. M., Pennica, D., Henderson, C. E. and Delapeyriere, O., 1998. 
Synergistic effects of Schwann- and muscle-derived factors on motoneuron survival involve GDNF and 
cardiotrophin-1 (CT-1). J Neurosc. 18, 1440-1448. 
Bowerman, M., Salsac, C., Bernard, V., Soulard, C., Dionne, A., Coque, E., Benlefki, S., Hince, P., Dion, 
P. A., Butler-Browne, G., Camu, W., Bouchard, J. P., Delpire, E., Rouleau, G. A., Raoul, C. and Scamps, 
F., 2017. KCC3 loss-of-function contributes to Andermann syndrome by inducing activity-dependent 
neuromuscular junction defects. Neurobiol Dis. 106, 35-48. 
Camerino, G. M., Fonzino, A., Conte, E., De Bellis, M., Mele, A., Liantonio, A., Tricarico, D., Tarantino, 
N., Dobrowolny, G., Musaro, A., Desaphy, J. F., De Luca, A. and Pierno, S., 2019. Elucidating the 
Contribution of Skeletal Muscle Ion Channels to Amyotrophic Lateral Sclerosis in search of new 
therapeutic options. Sci Rep. 9, 3185. 
Charge, S. B. and Rudnicki, M. A., 2004. Cellular and molecular regulation of muscle regeneration. 
Physiol Rev. 84, 209-238. 
Da Cruz, S., Parone, P. A., Lopes, V. S., Lillo, C., McAlonis-Downes, M., Lee, S. K., Vetto, A. P., 
Petrosyan, S., Marsala, M., Murphy, A. N., Williams, D. S., Spiegelman, B. M. and Cleveland, D. W., 
2012. Elevated PGC-1alpha activity sustains mitochondrial biogenesis and muscle function without 
extending survival in a mouse model of inherited ALS. Cell Metab. 15, 778-786. 
Das, M., Rumsey, J. W., Bhargava, N., Stancescu, M. and Hickman, J. J., 2009. Skeletal muscle tissue 
engineering: a maturation model promoting long-term survival of myotubes, structural development of 
the excitation-contraction coupling apparatus and neonatal myosin heavy chain expression. 
Biomaterials. 30, 5392-5402. 
Derave, W., Eijnde, B. O. and Hespel, P., 2003. Creatine supplementation in health and disease: what 
is the evidence for long-term efficacy? Mol Cell Biochem. 244, 49-55. 
Dobrowolny, G., Aucello, M., Rizzuto, E., Beccafico, S., Mammucari, C., Boncompagni, S., Belia, S., 
Wannenes, F., Nicoletti, C., Del Prete, Z., Rosenthal, N., Molinaro, M., Protasi, F., Fano, G., Sandri, M. 
and Musaro, A., 2008. Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab. 
8, 425-436. 
Dobrowolny, G., Lepore, E., Martini, M., Barberi, L., Nunn, A., Scicchitano, B. M. and Musaro, A., 2018. 
Metabolic Changes Associated With Muscle Expression of SOD1(G93A). Front Physiol. 9, 831. 
Dumont, N. A., Wang, Y. X. and Rudnicki, M. A., 2015. Intrinsic and extrinsic mechanisms regulating 
satellite cell function. Development. 142, 1572-1581. 
Dupuis, L., Gonzalez de Aguilar, J. L., Echaniz-Laguna, A., Eschbach, J., Rene, F., Oudart, H., Halter, 
B., Huze, C., Schaeffer, L., Bouillaud, F. and Loeffler, J. P., 2009. Muscle mitochondrial uncoupling 
dismantles neuromuscular junction and triggers distal degeneration of motor neurons. PLoS One. 4, 
e5390. 
Ferri, A., Nencini, M., Battistini, S., Giannini, F., Siciliano, G., Casali, C., Damiano, M. G., Ceroni, M., 
Chio, A., Rotilio, G. and Carri, M. T., 2004. Activity of protein phosphatase calcineurin is decreased in 
sporadic and familial amyotrophic lateral sclerosispatients. J Neurochem. 90, 1237-1242. 
Henriquez, J. P., Webb, A., Bence, M., Bildsoe, H., Sahores, M., Hughes, S. M. and Salinas, P. C., 
2008. Wnt signaling promotes AChR aggregation at the neuromuscular synapse in collaboration with 
agrin. Proc Natl Acad Sci U S A. 105, 18812-18817. 
Lamotte d'Incamps, B., Bhumbra, G. S., Foster, J. D., Beato, M. and Ascher, P., 2017. Segregation of 
glutamatergic and cholinergic transmission at the mixed motoneuron Renshaw cell synapse. Sci Rep. 
7, 4037. 
Loeffler, J. P., Picchiarelli, G., Dupuis, L. and Gonzalez De Aguilar, J. L., 2016. The Role of Skeletal 
Muscle in Amyotrophic Lateral Sclerosis. Brain Pathol. 26, 227-236. 
Lorenzon, P., Bernareggi, A., Degasperi, V., Nurowska, E., Wernig, A. and Ruzzier, F., 2002. Properties 
of primary mouse myoblasts expanded in culture. Exp Cell Res. 278, 84-91. 
Maimon, R., Ionescu, A., Bonnie, A., Sweetat, S., Wald-Altman, S., Inbar, S., Gradus, T., Trotti, D., Weil, 
M., Behar, O. and Perlson, E., 2018. miR126-5p Downregulation Facilitates Axon Degeneration and 




































































Manzano, R., Toivonen, J. M., Calvo, A. C., Olivan, S., Zaragoza, P., Rodellar, C., Montarras, D. and 
Osta, R., 2013. Altered in vitro proliferation of mouse SOD1-G93A skeletal muscle satellite cells. 
Neurodegener Dis. 11, 153-164. 
McLoon, L. K., Harandi, V. M., Brannstrom, T., Andersen, P. M. and Liu, J. X., 2014. Wnt and extraocular 
muscle sparing in amyotrophic lateral sclerosis. Invest Ophthalmol Vis Sci. 55, 5482-5496. 
Nishimaru, H., Restrepo, C. E., Ryge, J., Yanagawa, Y. and Kiehn, O., 2005. Mammalian motor neurons 
corelease glutamate and acetylcholine at central synapses. Proc Natl Acad Sci U S A. 102, 5245-5249. 
Olson, E. N. and Williams, R. S., 2000. Calcineurin signaling and muscle remodeling. Cell. 101, 689-
692. 
Oppenheim, R. W., 1989. The neurotrophic theory and naturally occurring motoneuron death. Trends 
Neurosci. 12, 252-255. 
Palamiuc, L., Schlagowski, A., Ngo, S. T., Vernay, A., Dirrig-Grosch, S., Henriques, A., Boutillier, A. L., 
Zoll, J., Echaniz-Laguna, A., Loeffler, J. P. and Rene, F., 2015. A metabolic switch toward lipid use in 
glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis. EMBO 
Mol Med. 7, 526-546. 
Pierno, S., Desaphy, J. F., Liantonio, A., De Bellis, M., Bianco, G., De Luca, A., Frigeri, A., Nicchia, G. 
P., Svelto, M., Leoty, C., George, A. L., Jr. and Camerino, D. C., 2002. Change of chloride ion channel 
conductance is an early event of slow-to-fast fibre type transition during unloading-induced muscle 
disuse. Brain. 125, 1510-1521. 
Pradat, P. F., Barani, A., Wanschitz, J., Dubourg, O., Lombes, A., Bigot, A., Mouly, V., Bruneteau, G., 
Salachas, F., Lenglet, T., Meininger, V. and Butler-Browne, G., 2011. Abnormalities of satellite cells 
function in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 12, 264-271. 
Pun, S., Santos, A. F., Saxena, S., Xu, L. and Caroni, P., 2006. Selective vulnerability and pruning of 
phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat Neurosci. 9, 408-419. 
Raoul, C., Estevez, A. G., Nishimune, H., Cleveland, D. W., deLapeyriere, O., Henderson, C. E., Haase, 
G. and Pettmann, B., 2002. Motoneuron death triggered by a specific pathway downstream of Fas. 
potentiation by ALS-linked SOD1 mutations. Neuron. 35, 1067-1083. 
Sanes, J. R. and Lichtman, J. W., 2001. Induction, assembly, maturation and maintenance of a 
postsynaptic apparatus. Nat Rev Neurosci. 2, 791-805. 
Schiaffino, S. and Reggiani, C., 2011. Fiber types in mammalian skeletal muscles. Physiol Rev. 91, 
1447-1531. 
Schram, S., Chuang, D., Schmidt, G., Piponov, H., Helder, C., Kerns, J., Gonzalez, M., Song, F. and 
Loeb, J. A., 2019. Mutant SOD1 prevents normal functional recovery through enhanced glial activation 
and loss of motor neuron innervation after peripheral nerve injury. Neurobiol Dis. 124, 469-478. 
Shen, C., Li, L., Zhao, K., Bai, L., Wang, A., Shu, X., Xiao, Y., Zhang, J., Zhang, K., Hui, T., Chen, W., 
Zhang, B., Hsu, W., Xiong, W. C. and Mei, L., 2018. Motoneuron Wnts regulate neuromuscular junction 
development. Elife. 7. 
Smith, A. S., Long, C. J., Pirozzi, K. and Hickman, J. J., 2013. A functional system for high-content 
screening of neuromuscular junctions in vitro. Technology (Singap World Sci). 1, 37-48. 
Smittkamp, S. E., Morris, J. K., Bomhoff, G. L., Chertoff, M. E., Geiger, P. C. and Stanford, J. A., 2014. 
SOD1-G93A mice exhibit muscle-fiber-type-specific decreases in glucose uptake in the absence of 
whole-body changes in metabolism. Neurodegener Dis. 13, 29-37. 
Taylor, J. P., Brown, R. H., Jr. and Cleveland, D. W., 2016. Decoding ALS: from genes to mechanism. 
Nature. 539, 197-206. 
Towne, C., Raoul, C., Schneider, B. L. and Aebischer, P., 2008. Systemic AAV6 delivery mediating RNA 
interference against SOD1: neuromuscular transduction does not alter disease progression in fALS 
mice. Mol Ther. 16, 1018-1025. 
Tremblay, E., Martineau, E. and Robitaille, R., 2017. Opposite Synaptic Alterations at the 
Neuromuscular Junction in an ALS Mouse Model: When Motor Units Matter. J Neurosc. 37, 8901-8918. 
Ullian, E. M., Harris, B. T., Wu, A., Chan, J. R. and Barres, B. A., 2004. Schwann cells and astrocytes 
induce synapse formation by spinal motor neurons in culture. Mol Cell Neurosci. 25, 241-251. 
Varga, B., Martin-Fernandez, M., Hilaire, C., Sanchez-Vicente, A., Areias, J., Salsac, C., Cuisinier, F. J. 
G., Raoul, C., Scamps, F. and Gergely, C., 2018. Myotube elasticity of an amyotrophic lateral sclerosis 
mouse model. Sci Rep. 8, 5917. 
Vilmont, V., Cadot, B., Ouanounou, G. and Gomes, E. R., 2016. A system for studying mechanisms of 
neuromuscular junction development and maintenance. Development. 143, 2464-2477. 
Williamson, T. L. and Cleveland, D. W., 1999. Slowing of axonal transport is a very early event in the 
toxicity of ALS-linked SOD1 mutants to motor neurons. Nat Neurosci. 2, 50-56. 
Wong, M. and Martin, L. J., 2010. Skeletal muscle-restricted expression of human SOD1 causes motor 




































































Yamanaka, K. and Komine, O., 2018. The multi-dimensional roles of astrocytes in ALS. Neurosci Res. 
126, 31-38. 
Zahavi, E. E., Ionescu, A., Gluska, S., Gradus, T., Ben-Yaakov, K. and Perlson, E., 2015. A 
compartmentalized microfluidic neuromuscular co-culture system reveals spatial aspects of GDNF 
functions. J Cell Sci. 128, 1241-1252. 






Movie 1: Live imaging of myotube contractions showing the serial effects of CNQX, d-TC and TTX 
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Fig. 1. Pharmacological characterization of spontaneous activity of motoneurons and myotubes in 
primary culture. (A) Primary culture of ventral horn contains Hb9::GFP positive motoneurons showing 
co-expression with the cholinergic marker VAChT in soma and neurites. Motoneurons also express the 
glutamatergic marker, VGluT2 (left). Hb9::GFP negative interneurons express VGluT2, not VAChT 
(right). (B) Immunolabeling with the astrocyte marker S100β reveals the presence of glial cells in ventral 
horn culture. (C) Extracellular recordings of spontaneous electrical activity of 2 different motoneurons in 
the presence (or not) of the ionotropic glutamate receptor AMPA/Kainate inhibitor, CNQX or the 
ionotropic nicotinic receptor inhibitor, d-TC, with the loose patch technique. (D) Quantification of 
motoneuron spontaneous activity before (control) and following addition of 50 µM CNQX (paired, two-
tailed t test, t(3) = 4.572, R2 = 0.874, p ≤ 0.05). (E) Inhibition of nicotinic receptors with 50 µM d-TC has 
no effect on motoneuron spontaneous activity (paired, two-tailed t test, t(4) = 1.485, p ≥ 0.05). Values are 
means ± SEM, number of cells is in bracket. (F) Representative phase contrast image of 8 DIV primary 
myotube culture. Part of a contracting myotube is selected for live imaging (selection box in red). 
Changes in contrast in selected pixels due to myotube movement allows quantification of a contraction. 
(G) Illustration of contractions recordings of a myotube (control) and following CNQX, d-TC and TTX 
application (parallel bars indicates interruption of recordings during drug application). Note that the 
apparent noise increase of baseline under d-TC is actually due to myotube fibrillation (see corresponding 
movie 1). TTX further reduces baseline noise and stops contractions. (H) Analysis of myotube 
contraction frequency. Application of 50 µM CNQX does not modify spontaneous frequency (two-tailed 
t test, t(18) = 0.05, F(9,9) = 1.003, p ≥ 0.05). Inhibition of nicotinic receptors with 50 µM d-TC induces low 
amplitude, high frequency contractions (two-tailed t test, t(17) = 3.344, R2 = 0.396, p ≤ 0.01; F(8,9) = 3.571, 
p ≥ 0.05). Addition of 1 µM TTX that inhibits electrical activity stops the low amplitude, high frequency 
contractions (two-tailed t test, t(15) = 6.329, R2 = 0.727, p ≤ 0.0001). (I) Illustration of combined recordings 
of myotube contraction with videomicroscopy (upper trace) and electrical activity with the loose patch-
technique (lower trace). 
 
Fig. 2. Characterization of spontaneous activity of motoneuron and myotube in co-culture. (A) The 
presence of neurons in myotube culture increases the number of contracting myotubes (3.7 ± 1.3 
contracting myotubes per well, n = 4 independent cultures, to 7.7 ± 0.5 contracting myotubes per well, 
n = 4 independent co-cultures (Mann Whitney test, U(10,26) = 0, p ≤ 0.05). (B) Confocal image of a NMJ 
obtained with immunostaining of motoneuron (GFP, green) contacting acetylcholine receptors (αBTX, 
red) expressed on a myotube (MHC, purple). (C) Staining of a NMJ expressing the post-synaptic marker, 
Rapsyn, facing the nicotinic receptors (BTX) and the pre-synaptic neuronal marker VAChT. (D) 
Representative phase contrast image of 8 DIV neuron-myotube live co-culture. (E) corresponding 
fluorescent image of the co-culture showing the GFP-positive Hb9::GFP motoneurons. (F) Addition of 



































































F(26,7) = 2.5777, p ≥ 0.05). (G) Addition of myotubes increases the spontaneous activity of motoneurons 
(from 0.5 ± 0.1 Hz, n = 22 to 1.5 ± 0.3 Hz, n = 29); (two-tailed t test, t(49) = 2.323, F(28,21) = 10.94, R2 = 
0.099, p ≤ 0.05, from 3 WT co-cultures). 
 
Fig. 3. SOD1G93A myotubes co-cultured with WT motoneurons have a decreased contraction frequency. 
(A) Overexpression of SOD1G93A in myotubes significantly decreases the contraction frequency 
measured using electrical spikes (1.7 ± 0.2 Hz, n = 27 and 0.9 ± 0.1 Hz, n = 34, for WT and mutant 
myotubes, respectively (two-tailed t test, t(59) = 2.952, R2 = 0.1287, p ≤ 0.01; F(33, 26) = 2.177, p ≤ 0.05;). 
(B) Combining videomicroscopy with loose patch clamp for contraction and electrical activity recordings 
shows synchronization between the two activities. (C) Mutant myotubes retain the synchronization 
between contraction and electrical spike. (D) Mutant myotubes do not modify the frequency of Hb9::GFP 
motoneuron spontaneous activity (two-tailed t test, t(47) = 0.403, p ≥ 0.05; F(28,19) = 1.611, p ≥ 0.05). 
 
Fig. 4. SOD1G93A decreases the expression of the slow myosin heavy chain isoform in myotubes. (A) 
Phase contrast image of cultured myoblasts; (B) phase contrast image of myotubes after 7 days in 
differentiation medium. (C) Quantitative RT-PCR of Pax7 shows decreased expression in WT and 
mutant myotubes compared with myoblasts (Mann-Whitney test, U(4,4) = 0, p ≤ 0.05 and U(.5, 5) = 0, p ≤ 
0.01, for WT and SOD1G93A, respectively. (D) Ckm expression significantly increases in both WT and 
mutated myotubes (Mann-Whitney test, U(4, 4) = 0, p ≤ 0.05, for WT and SOD1G93A, respectively. (E-I) 
Quantitative RT-PCR of myosin heavy chain isoforms expressed in skeletal muscle. All isoforms are 
expressed, except Mhy1. (Mann-Whitney test: Mhy3: U(4,4) = 4, p ≥ 0.05, for WT and SOD1G93A, 
respectively; Myh8: U(4,4) = 0, p ≤ 0.05, for WT and SOD1G93A, respectively; Myh2: U(4,4) = 4, p ≥ 0.05, 
for WT and SOD1G93A, respectively; Myh4: U(4,4) = 0, p ≤ 0.05, for WT and SOD1G93A, respectively; Myh7: 
U(5,5) = 11, p ≥ 0.05, and U(6,6) = 3, p ≤ 0.05, for WT and SOD1G93A, respectively). 
 
Fig. 5. Expression of SOD1G93A in motoneuron reduced glutamate-driven contraction of mutant 
myotubes. (A, B) In the presence of WT motoneurons, CNQX inhibited most contractions of WT and 
SOD1G93A myotubes. (C, D) Expression of SOD1G93A in motoneurons drastically decreases the number 
of SOD1G93A and WT myotubes responding to CNQX inhibition. (E) The percentage of myotubes 
contractions inhibited by CNQX is 89 %, 78 %, 22 % and 11 % in WT co-cultures (WT/WT), in mixed 
mutant myotubes/WT motoneurons (SOD1G93A/WT), mutant co-culture (SOD1G93A/SOD1G93A) and WT 
myotubes/mutant motoneurons (WT/ SOD1G93A), respectively (WT/WT vs SOD1G93A/WT: X2, df = 9.899, 
3, p ≥ 0.05; WT/WT vs SOD1G93A/SOD1G93A : X2, df = 9.899, 3, p ≤ 0.05; WT/WT vs WT/ SOD1G93A : X2, 






































































Table 1. Primers. Name, sequence, amplicon length (Al) and melting point (Tm) of primers used for 
qRT-PCR are listed below. 
Target genes Sequences Al Tm 
Pax7 










(adult Myosin Heavy Chain IIx) 
Myh2 
(adult Myosin Heavy Chain IIa) 
Myh3 
























(adult Myosin Heavy Chain IIb) 
Myh7 
(adult Myosin Heavy Chain-beta) 
Myh8 
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